Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
about
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapiesClinical and laboratory prognostic indicators in chronic lymphocytic leukemiaLipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients.Detection, analysis and clinical validation of chromosomal aberrations by multiplex ligation-dependent probe amplification in chronic leukemia.The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cellsCLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progressionPrognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemiaThe novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaIGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemiaTLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patientsmiR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies.Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemiaChronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemia.Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceAcute liver failure because of chronic lymphocytic leukemia: case report and review of the literature.Relevance of IgVH gene somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma.ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia.HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence--clinical implication and comparison between the West and the East.IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events.A 23-year-old woman with 11q-chronic lymphocytic leukemia.Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations.Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.IRF-3 gene polymorphisms are associated with the susceptibility to and the survival in chronic lymphocytic leukemia and could also serve as an auxiliary index.
P2860
Q24605471-BEFE1837-5673-42A6-9309-8E8370405970Q26830323-A4F7F297-2462-4B99-AC8D-56562E869A4BQ30248557-37551867-099B-4D91-AB28-51067EAEB963Q33517828-F8DAD41F-7CA6-4642-9953-68DAA377F5CEQ33700437-939E72C7-27BA-4A7B-A87F-D24FD26D0018Q33737795-FE5F815D-A557-4F89-BABB-613E4F47E354Q33952785-41AFFFC5-43F9-4864-B87B-DADC66A9DFFFQ34656369-36000BE7-79D8-41C5-A69F-8B1B7F71C426Q34781837-55C2DFD0-250A-46D6-8623-345C45BCB78AQ35011166-B9A61C39-EB4D-4F18-98EE-E3B1D2AADEBFQ35036721-07954219-7259-4972-AF92-6D7C24E67E8CQ35584788-BDC12F30-D5C4-4499-8B95-64DCF62E2167Q35629314-46C2B7D5-C9E1-4987-81CB-A09B2D21FEF1Q35707206-6665D7C8-00D9-4AED-94FA-F5EF243BD7E7Q35814897-0A69921F-F092-4BF8-98FB-CFEFB0608867Q35861964-55CA06C5-9ED8-4FA1-BB99-EF5213A2AF70Q36212773-9BA089F2-DF80-4508-A5D0-03F8076A51E7Q36247617-34566D29-7BE2-4F0B-B442-8C3AF1DE7731Q36824956-0E93814A-03E8-4379-9C0F-669DB7462B8AQ36906625-2C0431E1-02E4-4D2F-9D7E-6BB93D82071DQ37111327-6C0C2313-A2F6-48BF-A53F-37CD3C76A8BDQ37480308-3066377E-BD9B-4D50-A136-468D2E0E5E5EQ37844428-280E9E12-A6E7-4ED1-B1EA-EF41C66BC19EQ38410498-0BACAC4D-FE6F-4250-AE21-E35717CB207DQ38891225-9475D7FF-4612-4052-BD3C-7B39E42C4FC3Q40083143-6D0E1BCD-7EF6-43A0-ABE9-A949656C599FQ42426152-B34A2D5B-5897-4291-9A2F-BB4B50EAA5FCQ44052238-B9677508-91E3-4737-88FD-09EA8E12E197Q44563802-ABB39C3A-C90E-4C15-A8B1-B6E00B88DBBCQ47552836-8538EAC8-6172-41AD-84C6-77DAB5E5C7C3Q47916143-A5072B49-77A6-4B30-9016-9ED9CB441481Q49106175-66755D42-F76B-4EF1-AC7C-9368F419FF07Q51039630-6AA0B770-925E-4302-9A08-37DD39EB1747Q53048153-037DB02B-8D00-409E-BB17-969BAC1BC76CQ53119796-9AB2DD2C-8161-486D-B890-7D034C545F4DQ53147192-A440AE48-2C0B-49EB-8DAF-777D9BBF9382Q53326016-AD1986A3-DE4E-4551-98A6-512DA302954CQ54308638-6B03E127-D9E2-456E-A430-E2A78DF4168FQ55057300-65854293-3695-4EFA-9F0E-8454E8B08CD5Q55059774-5D4BA2AC-DC00-4418-A001-01EAFCC0FFA6
P2860
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@en
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@nl
type
label
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@en
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@nl
prefLabel
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@en
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@nl
P2093
P1433
P1476
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
@en
P2093
Bruno Verhasselt
Femke Van Bockstaele
Jan Philippé
P356
10.1016/J.BLRE.2008.05.003
P577
2008-07-02T00:00:00Z